Mercia Asset Management (MERC)

Sector:

Financials

Index:

FTSE AIM All-Share

 30.80p
   
  • Change Today:
      0.000p
  • 52 Week High: 36.50p
  • 52 Week Low: 27.00p
  • Currency: UK Pounds
  • Shares Issued: 431.30m
  • Volume: 104,197
  • Market Cap: £132.84m
  • RiskGrade: 167

Mercia Asset Management makes two new direct invesments

By Josh White

Date: Tuesday 18 Oct 2022

LONDON (ShareCast) - (Sharecast News) - Regionally-focussed specialist asset manager Mercia Asset Management announced two new direct investments on Tuesday, into Axis Spine Technologies and Nova Pangaea Technologies.
The AIM-traded firm said the investment into Axis Spine came as part of a £10.8m funding round, with Mercia making a direct investment of £3m, alongside £3.8m from its managed funds.

MedTex Ventures, a US-based venture capital firm focused on the medical device industry, invested £3m, with the remaining £1m coming from other external investors.

Mercia said its managed funds first invested in Axis Spine in 2017.

Following the investment, Mercia held an 11.7% fully-diluted direct equity stake in Axis Spine, with funds managed by Mercia holding a further 33.6% fully-diluted equity stake.

"Axis Spine is a medical technology business delivering spinal implants," the board explained.

"Axis has a highly differentiated platform of modular implants, designed to address the increasingly recognised and unmet clinical need of cage subsidence.

"This technology promises to not only reduce postoperative spinal segment collapse, but also improve spinal alignment in patients suffering chronic back pain and spinal deformity."

Insertion of Axis' proprietary modular cages required "much less force" than conventional implants, as they are slimmer and have a wider footprint, thus reducing the risk of damage to vertebral segment endplates and the loss of alignment that impacts one in three patients.

The investment into Nova Pangaea, meanwhile, was part of a £5.3m funding round, with Mercia making an initial direct investment of £2.3m via a convertible loan, alongside £1m from its Northern Powerhouse Investment Fund (NPIF) and a further £2m from co-investors.

It described Nova Pangaea as a clean technology business focussed on creating biofuels and biochar to address some of the most pressing climate concerns.

Led by chief executive Sarah Ellerby, Nova Pangaea provides a patented process called 'REFNOVA' that converts woody and agricultural residues into high-value sustainable products, used to manufacture sustainable aviation fuel and a range of biochemicals.

The process also produces biochar, which is "crucial" for carbon dioxide removal and soil enhancement.

"These are two businesses we have been excited about for some time, actively supporting them within our managed funds," said chief executive officer Mark Payton.

"We are pleased to welcome them onto our balance sheet, where we have significant liquidity to support both in reaching their next stage of maturity.

"Both embody what we look for in UK regional businesses, combining innovative technology with deep sector specialism to create real-world solutions."

At 1021 BST, shares in Mercia Asset Management were down 2.08% at 23.5p.

Reporting by Josh White at Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

MERC Market Data

Currency UK Pounds
Share Price 30.80p
Change Today 0.000p
% Change 0.00 %
52 Week High 36.50p
52 Week Low 27.00p
Volume 104,197
Shares Issued 431.30m
Market Cap £132.84m
RiskGrade 167

MERC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.36% above the market average20.36% above the market average20.36% above the market average20.36% above the market average20.36% above the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
34.58% above the market average34.58% above the market average34.58% above the market average34.58% above the market average34.58% above the market average
12.50% above the sector average12.50% above the sector average12.50% above the sector average12.50% above the sector average12.50% above the sector average
Income
80.51% below the market average80.51% below the market average80.51% below the market average80.51% below the market average80.51% below the market average
78.46% below the sector average78.46% below the sector average78.46% below the sector average78.46% below the sector average78.46% below the sector average
Growth
78.12% below the market average78.12% below the market average78.12% below the market average78.12% below the market average78.12% below the market average
80.39% below the sector average80.39% below the sector average80.39% below the sector average80.39% below the sector average80.39% below the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

MERC Dividends

  Latest Previous
  Final Interim
Ex-Div 03-Oct-24 07-Dec-23
Paid 01-Nov-24 10-Jan-24
Amount 0.55p 0.35p

Trades for 21-Nov-2024

Time Volume / Share Price
16:38 10,000 @ 31.25p
13:35 1 @ 31.57p
12:28 29,509 @ 30.50p
10:47 11,346 @ 31.25p
10:20 2,240 @ 31.25p

MERC Key Personnel

CEO Mark Andrew Payton
CFO Martin James Glanfield

Top of Page